NCT05043441

Brief Summary

This randomized controlled trial aims to assess the effects of a coach-guided ten-week videoconferencing acceptance and commitment therapy (ACT) program on mental health outcomes in depressed family caregivers of people with dementia (PwD) compared to the control group. A total of 32 family caregivers of PwD who meet the eligibility criteria will be recruited and randomized to either the intervention group or the control group. The hypotheses are that the ACT group will show improvements in depressive symptoms, other mental health outcomes, and ACT process measures at posttest and 3-month follow-up, compared to the control group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 5, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 14, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

March 21, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 18, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 18, 2024

Completed
Last Updated

October 9, 2024

Status Verified

October 1, 2024

Enrollment Period

2.2 years

First QC Date

September 5, 2021

Last Update Submit

October 6, 2024

Conditions

Keywords

Acceptance and Commitment TherapyAlzheimer's DiseaseBurdenCaregiversDementiaMindfulnessPsychological healthQuality of lifeSelf-compassionStressDepressionAnxietyGuiltGrief

Outcome Measures

Primary Outcomes (1)

  • Change from baseline to immediately after the intervention and 3 month follow-up on the Patient Health Questionnaire-9

    The Patient Health Questionnaire-9 is a 9-item questionnaire assessing depressive symptoms on a scale of 0 to 3. Scores range from 0 to 27. Higher scores indicate greater symptomatology in depression.

    Change from baseline to immediately after the intervention and 3 month follow-up

Secondary Outcomes (10)

  • Change from baseline to immediately after the intervention and 3 month follow-up on the Generalized Anxiety Disorder-7

    Change from baseline to immediately after the intervention and 3 month follow-up

  • Change from baseline to immediately after the intervention and 3 month follow-up on the Perceived Stress Scale

    Change from baseline to immediately after the intervention and 3 month follow-up

  • Change from baseline to immediately after the intervention and 3 month follow-up on the World Health Organization Quality of Life - Psychological health component

    Change from baseline to immediately after the intervention and 3 month follow-up

  • Change from baseline to immediately after the intervention and 3 month follow-up on the Meuser Caregiver Grief Inventory

    Change from baseline to immediately after the intervention and 3 month follow-up

  • Change from baseline to immediately after the intervention and 3 month follow-up on the Caregiver Guilt Questionnaire

    Change from baseline to immediately after the intervention and 3 month follow-up

  • +5 more secondary outcomes

Study Arms (2)

Acceptance and commitment therapy (ACT) group

EXPERIMENTAL

10 weekly ACT sessions individually guided by a trained coach through Zoom videoconferencing with psychoeducation materials provided

Behavioral: Acceptance and commitment therapy (ACT)

Psychoeducation control group

SHAM COMPARATOR

Care as usual with psychoeducation materials provided

Behavioral: Psychoeducation

Interventions

Caregivers assigned to this intervention group will receive individual ACT sessions guided by a trained coach for one hour per week over 10 weeks through Zoom videoconferencing with psychoeducation materials provided.

Acceptance and commitment therapy (ACT) group
PsychoeducationBEHAVIORAL

The psychoeducation control group will receive care as usual with psychoeducation materials provided.

Psychoeducation control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • community-dwelling adults (age 18 or over) who are currently taking the primary responsibility for the care of a relative with dementia living in the community
  • having at least mild depression as measured by the Patient Health Questionnaire (PHQ)-9
  • having a computer or a smartphone with the internet access at home and
  • being able to provide informed consent

You may not qualify if:

  • having cognitive, physical, or sensory deficits or language barriers (non-English communicator) that impede study participation
  • having psychiatric hospitalizations or diagnoses of mental illness in the previous two years
  • taking antipsychotic or anticonvulsant medication at the time of recruitment
  • considering or planning to place family members of PwD in a nursing home within 6 months or
  • having the possibility of study dropouts due to medical conditions of caregivers (e.g., surgery that may affect mental health) and their relatives with dementia (e.g., conditions that may impede study participation due to frequent hospitalization or death)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

Location

Related Publications (1)

  • Han A, Oster R, Yuen H, Jenkins J, Hawkins J, Edwards L. Videoconference-Delivered Acceptance and Commitment Therapy for Family Caregivers of People With Dementia: Pilot Randomized Controlled Trial. JMIR Form Res. 2025 Mar 31;9:e67545. doi: 10.2196/67545.

MeSH Terms

Conditions

DepressionAlzheimer DiseaseDementiaPsychological Well-BeingAnxiety Disorders

Interventions

Acceptance and Commitment Therapy

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersPersonal Satisfaction

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Areum Han, PhD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

September 5, 2021

First Posted

September 14, 2021

Study Start

March 21, 2022

Primary Completion

June 18, 2024

Study Completion

June 18, 2024

Last Updated

October 9, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations